Literature DB >> 1760605

Severe cystitis associated with tiaprofenic acid.

M Ahmed1, O W Davison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1760605      PMCID： PMC1671626          DOI： 10.1136/bmj.303.6814.1376

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states.

Authors:  E M Sorkin; R N Brogden
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

2.  N-(3',4'-dimethoxycinnamoyl)anthranillic acid, an antiallergic compound, induced eosinophilic cystitis.

Authors:  T Nakada; S Ishikawa; M Sakamota; T Katayama; T Igarashi; Y Mizumura; F Koizumi; H Shigematsu; T Fukuda
Journal:  Urol Int       Date:  1986       Impact factor: 2.089
  2 in total
  8 in total

1.  Treatment of refractory interstitial cystitis.

Authors:  A Morales; L Emerson; J C Nickel
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

2.  Tiaprofenic acid and severe cystitis.

Authors:  E G Brown; P C Waller; B A Sallie
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

3.  Cystitis and ureteric obstruction in patients taking tiaprofenic acid.

Authors:  F G Mayall; R W Blewitt; W G Staff
Journal:  BMJ       Date:  1994-09-03

4.  Tiaprofenic acid and cystitis.

Authors:  D N Bateman
Journal:  BMJ       Date:  1994-09-03

5.  Adverse reactions to tiaprofenic acid mimicking interstitial cystitis.

Authors:  W J Harrison; R G Willis; D E Neal
Journal:  BMJ       Date:  1994-09-03

Review 6.  Current pharmacological treatment of osteoarthritis.

Authors:  F A Wollheim
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 7.  Drug-induced bladder and urinary disorders. Incidence, prevention and management.

Authors:  M J Drake; P M Nixon; J P Crew
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

Review 8.  Tiaprofenic acid. A reappraisal of its pharmacological properties and use in the management of rheumatic diseases.

Authors:  G L Plosker; A J Wagstaff
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.